AzTrials
AzTrials

Neonatal Intensive Care UnitSMVP-NICUNCT06839534

Effects of a Structured Maternal Voice Program on Premature Infant Responses and Maternal-Infant Attachment in the Neonatal Intensive Care Unit

A study testing Structured Maternal Voice Program (SMVP) in people with Neonatal Intensive Care Unit and PreTerm Neonate, run by Chulalongkorn University at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the effects of a Structured Maternal Voice Program (SMVP). on premature infant responses and maternal-infant attachment in the intensive care unit (NICU) . Using a quasi-experimental crossover design, 16 mother-infant pairs (gestational age 32-36 weeks) were randomly assigned to experimental or… Read more about this study

Who is it for?
Ages Up to 36 weeksHealthy volunteers can take part
What is being tested?
Structured Maternal Voice Program (SMVP)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteThailand
Study dates
1 Oct 2023to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 36 weeks
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Preterm infants born at 32-36 weeks gestational age
  • Receiving care in the Neonatal Intensive Care Unit (NICU) at QSNICH
  • Stable vital signs with no severe medical complications that would interfere with auditory perception
  • Mothers willing and able to provide pre-recorded voice messages for SMVP
  • Parental informed consent obtained

Who cannot join

  • Critically unstable infants with severe medical complications (e.g., respiratory failure, severe metabolic acidosis)
  • Infants with diagnosed auditory or neurological impairments affecting response to maternal voice
  • Infants with severe intraventricular hemorrhage (Grade III or higher)
  • Mothers unable to provide pre-recorded voice messages due to health or psychological limitations
  • Families declining participation or withdrawing consent

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Faculty of Nursing, Chulalongkorn University

    Bangkok, Patumwan, 10330

Other trials in Thailand

About this study

Official title: The Effects of Maternal Voice Listening Program on Preterm Infant Responses and Maternal-Infant Attachment in the Neonatal Intensive Care Unit

This study evaluates the effects of a Structured Maternal Voice Program (SMVP). on premature infant responses and maternal-infant attachment in the intensive care unit (NICU) . Using a quasi-experimental crossover design, 16 mother-infant pairs (gestational age 32-36 weeks) were randomly assigned to experimental or control phases, with a four-day intervention and a one-day washout period. Infant responses and attachment outcomes were assessed using validated tools. Findings indicate significant improvements in motor activity, sleep states, and maternal-infant attachment scores, supporting the integration of maternal voice interventions in neonatal care.

Read the detailed description

Background \& Rationale Premature infants in the Neonatal Intensive Care Unit (NICU) face significant developmental challenges due to maternal separation and environmental stressors, such as excessive noise, bright lights, and invasive medical procedures. These stressors can negatively affect biobehavioral responses, including sleep-wake patterns, motor activity, and physiological stability. Moreover, the absence of maternal presence in NICUs can impair the maternal-infant attachment process, which is crucial for emotional bonding and neurodevelopment.

The Structured Maternal Voice Program (SMVP) is an innovative intervention designed to address these challenges by exposing preterm infants to their mother's voice through pre-recorded audio messages. This program is based on existing evidence that supports the role of maternal voice in stabilizing neonatal responses, promoting sleep regulation, and enhancing attachment. However, limited research has been conducted on the structured implementation of maternal voice exposure in NICUs, especially in settings where maternal visitation is restricted.

This study aims to evaluate the effectiveness of the SMVP in improving premature infant biobehavioral responses and maternal-infant attachment in a NICU setting.

Study Objectives

The primary objectives of this study are to:

Evaluate the impact of SMVP on premature infant responses, including motor activity, behavioral states, and sleep-wake patterns.

Assess changes in maternal-infant attachment scores before and after exposure to SMVP.

Study Design This study is a quasi-experimental crossover trial conducted at the Queen Sirikit National Institute of Child Health (QSNICH), Bangkok, Thailand. The study is designed to minimize confounding variables using a crossover design involving two groups.

Participants: 16 mother-infant pairs (infants born at 32-36 weeks gestational age) Randomization: Infants are randomly assigned to either the experimental phase (SMVP first) or the control phase (standard nursing care first) Washout Period: A one-day washout period between crossover sequences to prevent residual effects from the initial phase Duration: The intervention lasts four consecutive days per phase Intervention Details

The Structured Maternal Voice Program (SMVP) involves playing pre-recorded maternal voice messages through an MP3 player integrated into the incubator. The voice recordings consist of:

Recognition messages: Short affirmations such as "I'm so glad to have you." Soothing messages: Longer comforting phrases such as "Rest well, little one, you're safe with me."

Playback schedule:

Three times daily (morning, afternoon, and evening) Five-minute duration per session Calibrated at 55-60 dB to mimic intrauterine auditory experiences The control group receives standard nursing care without maternal voice exposure during the initial phase. After the washout period, the groups switch interventions.

Outcome Measures

Primary Outcomes:

Infant motor activity: including single limb movement, gross body movement, and head movement Infant behavioral states: including active sleep and quiet alert

Secondary Outcome:

Maternal-Infant Attachment Score, measured using the Maternal-Infant Attachment Questionnaire Significance

The findings from this study may:

Provide empirical evidence supporting the use of maternal voice exposure in NICUs as a structured intervention.

Offer a non-invasive, cost-effective intervention that enhances preterm infant stability and development.

Contribute to the integration of maternal voice programs into routine NICU care to improve outcomes for preterm infants.

Serve as a model for addressing maternal-infant separation in settings with restricted hospital visitation, ensuring both emotional and developmental needs are met for preterm infants.

Being tested
Structured Maternal Voice Program (SMVP)
Keywords
Premature Infants, Neonatal Intensive Care Unit, Maternal-Infant Attachment, Infant Behavioral Responses, Maternal Voice
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Structured Maternal Voice Program (SMVP)Behavioural

    Pre-recorded maternal voice messages played via an MP3 player integrated into the infant's incubator. The recordings include recognition messages ("I'm so glad to have you") and soothing messages ("Rest well, little one, you're safe with me"). The intervention is delivered three times daily for five minutes per session over a four-day period.

Study groups in NCT06839534
Study groupRoleWhat they receive
Structured Maternal Voice Program (SMVP)ExperimentalParticipants in this group receive the Structured Maternal Voice Program (SMVP) for four days, followed by standard nursing care for four days after a one-day washout period.
Receives: Behavioral: Structured Maternal Voice Program (SMVP)
Standard Nursing CareOtherParticipants in this group receive standard nursing care for four days, followed by the Structured Maternal Voice Program (SMVP) for four days after a one-day washout period.
Receives: Behavioral: Structured Maternal Voice Program (SMVP)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Premature Infant Responses

    Premature infant responses, including motor activity and behavioral states, will be assessed before, during, and after exposure to the Structured Maternal Voice Program (SMVP). The assessment will include:

    • Motor Activity: Single limb movement, gross body movement, head movement
    • Behavioral States: Active sleep, quiet alert Observations will be conducted by trained NICU nurses using a standardized Infant Response Assessment Tool. Responses will be recorded during each intervention phase and analyzed using repeated measures analysis.

    Measured: Four days of intervention per phase

Secondary outcomes (1)
  1. Maternal-Infant Attachment Score

    Maternal-infant attachment will be assessed before and after exposure to the Structured Maternal Voice Program (SMVP) using the Maternal-Infant Attachment Questionnaire (MIAQ). This validated tool measures maternal bonding and emotional connection with the infant, evaluating factors such as maternal sensitivity, affectionate behaviors, and perceived closeness. The questionnaire will be administered to mothers on Day 1 (pre-intervention) and Day 4 (post-intervention) of each phase. Statistical analyses will compare changes in attachment scores across conditions.

    Measured: Before and after the intervention phase (4 days per phase)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2025
  2. Study start1 Oct 2023
  3. Primary completion1 Sep 2024
  4. Study completion1 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Model description
This study uses a quasi-experimental crossover design to evaluate the effects of the Structured Maternal Voice Program (SMVP) on premature infant responses and maternal-infant attachment. Participants are randomly assigned to two sequences: (1) SMVP intervention followed by standard nursing care, or (2) standard nursing care followed by SMVP intervention. A one-day washout period is included between crossover phases to minimize residual effects.
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06839534
Sponsor's protocol ID
REC.097/2024
Acronym
SMVP-NICU
Status last verified
Feb 2025
First submitted
17 Feb 2025
Last updated
21 Feb 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Due to ethical considerations and the sensitive nature of neonatal and maternal-infant attachment data, individual participant data (IPD) will not be shared publicly. However, aggregated and de-identified results will be published in peer-reviewed journals and presented at scientific conferences.

Publications

  • Filippa M, Panza C, Ferrari F, Frassoldati R, Kuhn P, Balduzzi S, D'Amico R. Systematic review of maternal voice interventions demonstrates increased stability in preterm infants. Acta Paediatr. 2017 Aug;106(8):1220-1229. doi: 10.1111/apa.13832. Epub 2017 Apr 19.

    PubMed 28378337

Questions about this trial

What is this clinical trial studying?

A study testing Structured Maternal Voice Program (SMVP) in people with Neonatal Intensive Care Unit and PreTerm Neonate, run by Chulalongkorn University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Premature Infant Responses (time frame: Four days of intervention per phase). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06839534, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in